Home

Krebs Biochemicals & Industries Ltd PE Ratio

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PE

-

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Krebs Biochemicals & Industries Ltd is 0 as of 22 Feb 11:56 AM .
  • The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 85.5 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Krebs Biochemicals & Industries Ltd

No data available

Company Fundamentals for Krebs Biochemicals & Industries Ltd

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

Share Price

₹ 85.5

0.50 (0.59%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Krebs Biochemicals & Industries Ltd

1M

1Y

3Y

5Y

Monitoring Krebs Biochemicals & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202585.5
20 Feb 202585
19 Feb 202585
18 Feb 202582.09
17 Feb 202581.5
14 Feb 202582.8
13 Feb 202587.02
12 Feb 202589.11
11 Feb 202593.75
10 Feb 202598.3

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Krebs Biochemicals & Industries Ltd

Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Krebs Biochemicals & Industries Ltd184.34
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Krebs Biochemicals & Industries Ltd Explained

184.34

Market cap

-24

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Krebs Biochemicals & Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Krebs Biochemicals & Industries Ltd

No data available

* All values are in %

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

Krebs Biochemicals & Industries Ltd News Hub

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024

Read more

07 Aug 24

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company

Read more

09 Sept 24

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 N

Read more

29 Oct 24

Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September

Read more

11 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Krebs Biochemicals & Industries Ltd

What is the current PE Ratio of Krebs Biochemicals & Industries Ltd?

The Current PE Ratio of Krebs Biochemicals & Industries Ltd is 0.0 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Krebs Biochemicals & Industries Ltd last year?

The PE Ratio of Krebs Biochemicals & Industries Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Krebs Biochemicals & Industries Ltd indicate about its stock?

The PE Ratio of Krebs Biochemicals & Industries Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Krebs Biochemicals & Industries Ltd.

What is the PE Ratio Growth of Krebs Biochemicals & Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Krebs Biochemicals & Industries Ltd grew by -% whereas, the EPS ratio grew by 34.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions